HMGB1 and Sepsis: β-blockers can down-regulate inflammatory mediators (e.g., TNF-α, IL-6, HMGB-1) in animal models of sepsis to reduce the inflammatory response (13, 18, 19) as well as inhibit cardiomyocyte apoptosis (20, 21).